Evidence map›Paper›PMID 41894441›Full record

ArticlePloS one2026

Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoires.

Jasper Braun, Elliot D Hill, Elisa Contreras, Michie Yasuda, Alexandra Morgan, Sarah Ditelberg, Ethan Winter, Cody Callahan, Gabrielle Mazzoni, Andrea Kirmaier and 10 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Jasper BraunDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Elliot D HillDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Elisa ContrerasDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Michie YasudaDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Alexandra MorganDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Sarah DitelbergDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Ethan WinterDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Cody CallahanDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Gabrielle MazzoniDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Andrea KirmaierDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Ghee Rye LeeDepartment of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Hamid MirebrahimRoche Sequencing Solutions, Pleasanton, California, United States of America.
Hosseinali AsgharianRoche Sequencing Solutions, Pleasanton, California, United States of America.
Dilduz TelmanRoche Sequencing Solutions, Pleasanton, California, United States of America.
Ai-Ris Y CollierHarvard Medical School, Boston, Massachusetts, United States of America.
Dan H BarouchHarvard Medical School, Boston, Massachusetts, United States of America.
Stefan RiedelDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Sanjucta DuttaDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Florian RubeltRoche Sequencing Solutions, Pleasanton, California, United States of America.
Ramy ArnaoutDivision of Clinical Pathology, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-6955-9310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies and helper T cells play important roles in SARS-CoV-2 infection and vaccination. We sequenced B- and T-cell receptor repertoires (BCR/TCR) from the blood of 251 infectees, vaccinees, and controls to investigate whether features of these repertoires could predict subjects' SARS-CoV-2 neutralizing antibody titer (NAbs), as measured by enzyme-linked immunosorbent assay (ELISA). We sequenced recombined immunoglobulin heavy-chain (IGH), TCRβ (TRB), and TCRδ (TRD) genes in parallel from all subjects, including select B- and T-cell subsets in most cases, with a focus on their hypervariable CDR3 regions, and correlated this AIRRseq data with demographics and clinical findings from subjects' electronic health records. We found that age affected NAb levels in vaccinees but not infectees. Intriguingly, we found that vaccination and infection are associated with longer non-productively recombined IGHs, suggesting an effect that precedes clonal selection. We found that TRB repertoires' binding capacity to known SARS-CoV-2-specific CD4+ TRBs performs as well as the best hand-tuned approximate or "fuzzy" matching at predicting a protective level of NAbs, while also being more robust to repertoire sample size and not requiring hand-tuning. The overall conclusion from this large, unbiased, clinically well annotated dataset is that B- and T-cell adaptive responses to SARS-CoV-2 infection and vaccination are surprising, subtle, and diffuse. We discuss methodological and statistical challenges faced in attempting to define and quantify such strong-but-diffuse repertoire signatures and present tools and strategies for addressing these challenges.

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesReceptors, Antigen, T-CellSARS-CoV-2AdultAgedB-LymphocytesFemaleHumansImmunoglobulin Heavy ChainsMaleMiddle AgedReceptors, Antigen, T-Cell, alpha-betaVaccinationAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesImmunoglobulin Heavy ChainsReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID41894441
PMCPMC13028327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.